PETS Stock Analysis: Buy, Sell, or Hold?
PETS - PetMed Express, Inc.
$2.32
-0.04 (-1.69%)
▼
5d:
+0.43%
30d:
-15.33%
90d:
-27.5%
BUY
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
PETS is down 7.9% this week, but smart money is accumulating calls. Top strike: $2.5 2026-06-18 with 1,244 OI. Call ratio: 100% View Scanner →
Strength: 8.9/10
Get Alerted When PETS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PETS shows positive signals but monitor for confirmation. Market pricing in 6.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: PETS shows positive signals but monitor for confirmation. Market pricing in 6.7% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PETS is currently trading at $2.32, which is considered oversold relative to its 30-day fair value range of $2.32 to $2.71. From a valuation perspective, the stock is trading at a discount (Forward PE: 236.0) compared to its historical average (290.9). Remarkably, the market is currently pricing in an annual earnings decline of 6.7% over the next few years. This pessimistic expectation contrasts with the company's recent 266.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PETS is showing sideways momentum. Immediate support is located at $2.19, while resistance sits at $2.48.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Implied Volatility is high (74th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $2.75 (+16.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PETS is showing sideways momentum. Immediate support is located at $2.19, while resistance sits at $2.48.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Implied Volatility is high (74th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $2.75 (+16.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.32 -
$2.71
Company Quality Score
55/100
(HOLD)
Options IV Signal
74th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
62.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Options expensive (IV 74th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($2.75)
Fair Price Analysis
30-Day Fair Range
$2.32 -
$2.71
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.43
(18.6%)
Support & Resistance Levels
Support Level
$2.19
Resistance Level
$2.48
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
236.00
Wall Street Target
$2.75
(+16.5%)
Revenue Growth (YoY)
-21.7%
Earnings Growth (YoY)
266.7%
Profit Margin
-34.7%
Valuation Discount vs History
-6.7% cheaper
PE vs Historical
236.0 vs 290.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.7%
(market-implied from PE analysis)
1-Year Target
$2.20
(-7%)
2-Year Target
$2.05
(-13%)
3-Year Target
$1.92
(-19%)
3-Yr Target (if PE normalizes)
(PE: 236→291)
$2.36
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 236.0 to 290.9
Stabilization Target:
$2.91
(+23.3%)
PE Expansion Potential:
+23.3%
Share & Embed Analysis
Last updated: April 02, 2026 12:44 PM ET
Data refreshes hourly during market hours. Next update: 1:44 PM
Data refreshes hourly during market hours. Next update: 1:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PETS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Pharmaceutical Retailers Stocks
Top-rated stocks in Pharmaceutical Retailers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HITI
High Tide Inc |
STRONG BUY
5 analysts |
$6 | 50 HOLD |
